专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011119374A1 CONJUGATED POLYMERS AND DEVICES INCORPORATING SAME 审中-公开
标题翻译：结合聚合物和装置同时进行
公开(公告)号：WO2011119374A1
公开(公告)日：2011-09-29
申请号：PCT/US2011/028523
申请日：2011-03-15
申请人： POLYERA CORPORATION , FACCHETTI, Antonio , MARKS, Tobin, J. , HUANG, Hui , CHEN, Zhihua
发明人： FACCHETTI, Antonio , MARKS, Tobin, J. , HUANG, Hui , CHEN, Zhihua
IPC分类号： H01L51/00
CPC分类号： H01L51/0036 , C09B69/102 , C09B69/105 , C09B69/109 , H01L51/0043 , H01L51/0558 , Y02E10/549
摘要： Disclosed are conjugated polymers having desirable properties as semiconducting materials. Such polymers can exhibit desirable electronic properties and possess processing advantages including solution-processability and/or good stability.
摘要翻译：公开了具有期望性质的共轭聚合物作为半导体材料。这样的聚合物可以表现出所需的电子性质，并具有加工性和/或稳定性好的加工优点。

2. 发明申请

WO2015187449A1 PROCESS OF PRODUCING AND APPLICATIONS OF THREE COMPONENT BENZO[1,2-B:4,5-B] DITHIOPHENE-THIENOTHIOPHENE RANDOMLY SUBSTITUTED POLYMERS FOR ORGANIC SOLAR CELLS 审中-公开
标题翻译：三元组苯并[1,2-B：4,5-B]二苯基乙烯基苯并噻唑的有机太阳能电池的随机取代聚合物的生产和应用方法
公开(公告)号：WO2015187449A1
公开(公告)日：2015-12-10
申请号：PCT/US2015/032861
申请日：2015-05-28
申请人： PHILLIPS 66 COMPANY , WOODY, Kathy , HUANG, Hui , HE, Ting
发明人： WOODY, Kathy , HUANG, Hui , HE, Ting
IPC分类号： C08G61/12
CPC分类号： H01L51/0036 , H01L51/0043 , H01L51/0047 , H01L51/4253 , Y02E10/549
摘要： A process of polymerizing formula f with formula g and formula h wherein the stoichiometric ratio of f = (g+h) and f, g and h are not equal to 0. This process can also have R1 selected from the group consisting of alkyl group, alkoxy group, aryl groups and combinations thereof. Additionally, x and y can be different from each other.
摘要翻译：用式g和式h聚合式f的方法，其中f =（g + h）和f，g和h的化学计量比不等于0.该方法还可以具有选自烷基，烷氧基，芳基及其组合。另外，x和y可以彼此不同。

3. 发明申请

WO2013062856A1 SET MEMBERSHIP TESTERS FOR ALIGNING NUCLEIC ACID SAMPLES 审中-公开
标题翻译：用于对准核酸样品的成员测试仪
公开(公告)号：WO2013062856A1
公开(公告)日：2013-05-02
申请号：PCT/US2012/060892
申请日：2012-10-18
申请人： VERINATA HEALTH, INC. , BLUME, Erich, D. , BURKE, John, P. , HUANG, Hui
发明人： BLUME, Erich, D. , BURKE, John, P. , HUANG, Hui
IPC分类号： C12Q1/68 , G06F19/22
CPC分类号： C40B30/02 , G06F19/22
摘要： Disclosed are methods and tools for rapidly aligning reads to a reference sequence. These methods and tools employ Bloom filters or similar set membership testers to perform the alignment. The reads may be short sequences of nucleic acids or other biological molecules and the reference sequences may be sequences of genomes, chromosomes, etc. The Bloom filters include a collection of hash functions, a bit array, and associated logic for applying reads to the filter. Each filter, and there may be multiple of these used in a particular application, is used to determine whether an applied read is present in a reference sequence. Each Bloom filter is associated with a single reference sequence such as the sequence of a particular chromosome. In one example, chromosomal abundance is determined by aligning reads from a sequencer to multiple chromosomes, each having an associated Bloom filter or other set membership tester.
摘要翻译：公开了用于将读取快速对准到参考序列的方法和工具。这些方法和工具使用Bloom过滤器或类似的集成员测试器来执行对齐。读取可以是核酸或其他生物分子的短序列，并且参考序列可以是基因组，染色体等的序列。Bloom过滤器包括哈希函数的集合，位阵列和用于将读取应用于过滤器的相关逻辑。每个过滤器，并且在特定应用中可以使用这些过滤器中的多个，用于确定在参考序列中是否存在应用的读取。每个Bloom过滤器与单个参考序列相关联，例如特定染色体的序列。在一个实例中，染色体丰度通过将来自测序仪的读数与多个染色体对齐来确定，每个染色体具有相关的Bloom过滤器或其他集合隶属度测试器。

4. 发明申请

WO2011149841A1 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-α MODULATORS 审中-公开
标题翻译：作为雌激素相关受体 - 调节剂的替扎唑啉衍生物，吲哚酚和苯并噻唑
公开(公告)号：WO2011149841A1
公开(公告)日：2011-12-01
申请号：PCT/US2011/037571
申请日：2011-05-23
申请人： JANSSEN PHARMACEUTICA NV , BIGNAN, Gilles , CHEUNG, Wing , GAUL, Micheal , HUANG, Hui , LI, Xun , PATCH, Raymond , PATEL, Sharmila , PLAYER, Mark , XU, Guozhang , ZHAO, Bao-ping , LIU, Jian
发明人： BIGNAN, Gilles , CHEUNG, Wing , GAUL, Micheal , HUANG, Hui , LI, Xun , PATCH, Raymond , PATEL, Sharmila , PLAYER, Mark , XU, Guozhang , ZHAO, Bao-ping , LIU, Jian
IPC分类号： C07D417/06 , A61K31/427 , A61P7/00 , A61P11/00 , A61P19/00 , A61P35/00
CPC分类号： C07D417/06
摘要： The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.
摘要翻译：本发明涉及式（I）化合物，这些化合物的制备方法，组合物，中间体及其衍生物，用于治疗包括但不限于强直性脊柱炎，动脉粥样硬化，关节炎（如类风湿性关节炎，感染性关节炎，儿童期关节炎，牛皮癣关节炎，反应性关节炎），骨相关疾病（包括与骨形成相关的疾病），乳腺癌（包括对抗雌激素治疗无反应的那些），心血管疾病，软骨相关疾病（如软骨损伤/损失，软骨变性和与软骨形成相关的软骨变性），软骨发育不全，软骨肉瘤，慢性背部损伤，慢性支气管炎，慢性炎症性气道疾病，慢性阻塞性肺病，糖尿病，能量稳态障碍，痛风，假性呕吐，脂质障碍，代谢综合征骨髓瘤，肥胖症，骨关节炎，成骨不全，骨质溶解骨骨质疏松症，骨质疏松症，佩吉特氏病，牙周病，风湿性多肌痛，莱特综合征，重复性应激损伤，高血糖症，升高的血糖水平和胰岛素抵抗。

5. 发明申请

WO2007067719A3 DIAGNOSING HUMAN DISEASES BY DETECTING DNA METHYLATION CHANGES 审中-公开
公开(公告)号：WO2007067719A3
公开(公告)日：2007-06-14
申请号：PCT/US2006/046796
申请日：2006-12-07
申请人： AMBERGEN, INC. , WANG, Huajun , ANISOWICZ, Anthony , DEL MASTRO, Richard, G. , HUANG, Hui , MAMAEV, Sergey
发明人： WANG, Huajun , ANISOWICZ, Anthony , DEL MASTRO, Richard, G. , HUANG, Hui , MAMAEV, Sergey
IPC分类号： C12Q1/68 , C12P19/34 , C07H21/02 , C07H21/04
摘要： This invention relates to methodologies that detect global changes in the methylation of human genomic DNA as well as changes in methylation in specific regions of the human genome. The methodologies have utility in the diagnosis, prognosis and monitoring of therapeutic treatment for any human disease. Further, the invention relates to methodologies that can detect global changes in the melhylation of human genomic DNA that is a consequence of diet and/or dietary supplements. The invention also relates to identifying novel DNA methylation biomarkers that are associated with human disease.

6. 发明申请

WO2007033232A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE 审中-公开
标题翻译：作为C-FMS激酶的抑制剂的5-氧代-5,8-二氢吡啶并吡啶
公开(公告)号：WO2007033232A1
公开(公告)日：2007-03-22
申请号：PCT/US2006/035619
申请日：2006-09-13
申请人： JANSSEN PHARMACEUTICA, N.V. , PLAYER, Mark R. , HUANG, Hui , HUTTA, Daniel
发明人： PLAYER, Mark R. , HUANG, Hui , HUTTA, Daniel
IPC分类号： C07D471/04 , A61K31/519 , A61P9/00 , A61P29/00 , A61P35/00
CPC分类号： C07D471/04
摘要： The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula (I) or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein: W, A, Y, Z, R 101 and R 200 are described in the specification.
摘要翻译：本发明通过提供c-fms激酶的有效抑制剂来解决当前对选择性和有效的蛋白酪氨酸激酶抑制剂的需要。本发明涉及新的式（I）化合物或其溶剂化物，水合物，互变异构体或其药学上可接受的盐，其中：W，A，Y，Z，R 101和R 200在说明书中描述。

7. 发明申请

WO2007023330A1 METHOD AND DEVICE FOR SENDING AND RECEIVING GAME CONTENT INCLUDING DOWNLOAD THEREOF 审中-公开
标题翻译：用于发送和接收游戏内容的方法和装置，包括下载
公开(公告)号：WO2007023330A1
公开(公告)日：2007-03-01
申请号：PCT/IB2005/002526
申请日：2005-08-25
申请人： NOKIA CORPORATION , KOIVISTO, Ari, M. , RASANEN, Eero , WU, Yi , MA, Jian , HUANG, Hui , ZHANG, Dongmei , ARRASVUORI, Juha , HOLM, Jukka , ERONEN, Antti , MATTILA, Ville-Veikko , MATTILA, Jouka , SALOMAA, Jyri, P. , KANKAINEN, Ville
发明人： KOIVISTO, Ari, M. , RASANEN, Eero , WU, Yi , MA, Jian , HUANG, Hui , ZHANG, Dongmei , ARRASVUORI, Juha , HOLM, Jukka , ERONEN, Antti , MATTILA, Ville-Veikko , MATTILA, Jouka , SALOMAA, Jyri, P. , KANKAINEN, Ville
IPC分类号： A63F13/12 , H04H1/00 , H04L12/64 , H04N7/14
CPC分类号： A63F13/338 , A63F13/12 , A63F13/332 , A63F13/355 , A63F13/77 , A63F13/92 , A63F2300/204 , A63F2300/409 , A63F2300/552 , H04H20/57 , H04H20/91 , H04H20/95 , H04H60/68 , H04L67/04 , H04L67/38 , H04N21/41407 , H04N21/4781 , H04N21/6131 , H04N21/64315
摘要： The present invention generally relates to methods and devices as well as handheld stations and computer program products for sending video game content to handheld mobile terminals, comprising broadcasting common video game content to handheld mobile communication terminals via a digital video broadcast handheld channel, to enable said handheld mobile terminals to execute video game applications.
摘要翻译：本发明一般涉及用于向手持移动终端发送视频游戏内容的手持站和计算机程序产品，包括通过数字视频广播手持通道向手持移动通信终端广播公共视频游戏内容，以使所述手持移动终端执行视频游戏应用。

8. 发明申请

WO2018081047A1 CYCLOHEXYL GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES 审中-公开
标题翻译： CYCLOHEXYL GPR40激动剂用于治疗II型糖尿病
公开(公告)号：WO2018081047A1
公开(公告)日：2018-05-03
申请号：PCT/US2017/057979
申请日：2017-10-24
申请人： JANSSEN PHARMACEUTICA NV , HUANG, Hui
发明人： HUANG, Hui , LANTER, James C. , MEEGALLA, Sanath K. , PLAYER, Mark R.
IPC分类号： C07D213/63 , C07D213/68 , C07D257/04 , C07D263/20 , C07D401/12 , C07D403/12 , C07C43/20 , A61K31/421 , A61K31/4412 , A61K31/506 , A61P3/10
摘要： Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: (Formula (I)) wherein R 1 , R 2 , R 3 , A, W, L, R a , and G are defined herein: and by Formula (II) as follows: (Formula (II)) wherein R 1B , W B , L B , and G B are defined herein.
摘要翻译：公开了用于治疗受GPR40受体调节影响的病症的化合物，组合物和方法。这样的化合物如下式（I）所示：其中R 1，R 2，R 3，A和R 4如上所述的式（I），W，L，R a和/或G如本文所定义：和通过式（II）如下：其中R 1B，W _{B，L B和G B在本文中定义。}

9. 发明申请

WO2017027312A1 GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES 审中-公开
标题翻译： GPR40治疗II型糖尿病的药物
公开(公告)号：WO2017027312A1
公开(公告)日：2017-02-16
申请号：PCT/US2016/045523
申请日：2016-08-04
申请人： JANSSEN PHARMACEUTICA NV , HUANG, Hui
发明人： HUANG, Hui , MEEGALLA, Sanath , PLAYER, Mark R.
IPC分类号： C07D231/12 , C07D333/24 , C07D233/64 , C07D249/06 , C07D261/08 , C07D261/12 , C07D275/02 , C07D401/04 , C07D401/12 , C07D409/04 , A61K31/402 , A61K31/415 , A61K31/4192 , A61P3/10
CPC分类号： C07D413/12 , C07D231/12 , C07D233/64 , C07D249/06 , C07D261/08 , C07D261/12 , C07D275/02 , C07D333/24 , C07D401/04 , C07D401/12 , C07D409/04 , C07D413/04
摘要： Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (III); wherein R 1c , R 2C , R 4C , W c , Y c , Z c and G c , are defined herein.
摘要翻译：公开了用于治疗受GPR40受体调节影响的病症的化合物，组合物和方法。这些化合物由式（III）表示; 其中R1c，R2C，R4C，Wc，Yc，Zc和Gc在本文中定义。

10. 发明申请

WO2014200885A1 PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES 审中-公开
标题翻译： PDE10a抑制剂用于治疗II型糖尿病
公开(公告)号：WO2014200885A1
公开(公告)日：2014-12-18
申请号：PCT/US2014/041472
申请日：2014-06-09
申请人： JANSSEN PHARMACEUTICA NV , PLAYER, Mark R. , MEEGALLA, Sanath K. , ILLIG, Carl R. , CHEN, Jinsheng , WILSON, Kenneth J. , LEE, Yu-Kai , PARKS, Daniel J. , HUANG, Hui , PATEL, Sharmila , LU, Tianbao
发明人： PLAYER, Mark R. , MEEGALLA, Sanath K. , ILLIG, Carl R. , CHEN, Jinsheng , WILSON, Kenneth J. , LEE, Yu-Kai , PARKS, Daniel J. , HUANG, Hui , PATEL, Sharmila
IPC分类号： C07D487/04 , A61K31/519 , A61P3/10
CPC分类号： C07D519/00 , C07D487/04
摘要： Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows: wherein R 1 , R 2 , L, and Q are defined herein.
摘要翻译：公开了用于治疗II型糖尿病的化合物，组合物和方法。这样的化合物由式（I）表示如下：其中R 1，R 2，L和Q如本文所定义。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式